Completed PHASE4 INTERVENTIONAL 2-arm NCT01322308

Effect of Pioglitazone on Endothelial Function in Premenopausal Women With Uncomplicated Systemic Lupus Erythematosus

Effect of Pioglitazone on Endothelial Function in Premenopausal Women With Uncomplicated Systemic Lupus Erythematosus, a Randomized, Double-blind, Placebo-controlled Clinical Trial

Sponsor: National Council of Science and Technology, Mexico

Conditions Systemic Lupus Erythematosus

Interventions pioglitazone placebo

Updated 5 times since 2017 Last updated: Sep 30, 2014 Started: Mar 31, 2007 Primary completion: Jan 31, 2012 Completion: Jan 31, 2012

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE4 clinical study on Systemic Lupus Erythematosus, this trial is completed. The trial is conducted by National Council of Science and Technology, Mexico and has accumulated 5 data snapshots since 2007. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE4
Jul 2024 — Sep 2024 [monthly]

Completed PHASE4
Jan 2021 — Jul 2024 [monthly]

Completed PHASE4
Jun 2018 — Jan 2021 [monthly]

Completed PHASE4
Jan 2017 — Jun 2018 [monthly]

Completed PHASE4

First recorded

Mar 2007

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

National Council of Science and Technology, Mexico
National Heart Institute, Mexico
Universidad Nacional Autonoma de Mexico

Data source: National Heart Institute, Mexico

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

No location information available.